XML 30 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Equity
12 Months Ended
Dec. 31, 2018
Equity  
Equity

10. Equity

Common Stock.  We have an equity distribution agreement to issue and sell, from time to time, up to $200,000,000 in aggregate offering price of our company common shares. Sales of common shares will be made by means of ordinary brokers’ transactions, which may include block trades or transactions that are deemed to be “at the market” offerings.

During the year ended December 31, 2018, we sold 22,244 shares of common stock for $1,005,000 in net proceeds under our equity distribution agreement. In conjunction with the sale of common stock, we paid $18,000 as compensation to our sales agents and we reclassified $76,000 of accumulated costs associated with this agreement to additional paid in capital. Accordingly, at December 31, 2018, we had $184,139,000 available under our equity distribution agreement.

During the year ended December 31, 2017, we sold 312,881 shares of common stock for $14,600,000 in net proceeds under our equity distribution agreement. In conjunction with the sale of common stock, we paid $260,000 as compensation to our sales agents and we reclassified $49,000 of accumulated costs associated with this agreement to additional paid in capital.

During the years 2018, 2017 and 2016, we acquired 31,326 shares, 42,089 shares and 49,405 shares, respectively, of common stock held by employees who tendered owned shares to satisfy tax withholding obligations. Subsequent to December 31, 2018, we acquired 20,345 shares of common stock held by employees who tendered owned shares to satisfy tax withholding obligations.

Non-controlling Interests. During 2018 and 2017, we entered into partnerships to develop and/or own real estate. Given that our limited members do not have the substantive kick-out rights, liquidation rights, or participation rights, we have concluded that the partnerships are VIEs. Since we exercise power over and receive benefits from the VIEs, we are considered the primary beneficiary. Accordingly, we consolidate the VIEs and record the non-controlling interests at cost. As of December 31, 2018, we have the following consolidated VIEs (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross

 

 

 

 

Investment

 

 

 

Property

 

 

 

 

Consolidated

 

 

Non-Controlling

 

Year (1)

 

Purpose

 

Type

 

State

 

 

Assets

 

 

Interests

 

2018

 

Owned real estate

 

ILF

 

OR

 

$

14,400

(2)

$

2,857

(2)

2018

 

Owned real estate and development

 

UDP

 

OR

 

 

4,606

(2)

 

1,081

(2)

2017

 

Owned real estate and development

 

UDP

 

WI

 

 

16,665

(3)

 

2,272

(3)

2017

 

Owned real estate

 

ALF

 

SC

 

 

11,195

 

 

1,271

 

Total

 

 

 

 

 

 

 

$

46,866

 

$

7,481

 


(1)

Subsequent to December 31, 2018, we entered into a JV to purchase an existing operational 74-unit ALF/MC community. The non-controlling partner contributed $919 of equity and we contributed $15,950 in cash. Our economic interest in the real estate JV will be approximately 95%. We account for the JV on a consolidated basis.

 

(2)

We entered into a JV to develop, purchase and own seniors housing properties. During 2018, the JV purchased land for the development of a 78-unit ALF/MC for a total anticipated project cost of $18,108. The non-controlling partner contributed $1,081 of cash and we committed to fund the remaining $17,027 project cost. Additionally, during 2018, in a sale-leaseback transaction, the JV purchased an existing operational 89-unit ILF adjacent to the 78-unit ALF/MC we are developing for $14,400. The non-controlling partner contributed $2,857 of equity and we contributed $11,543 in cash. Upon completion of the development project, our combined economic interest in the JV will be approximately 88%. We account for the JV on a consolidated basis.   

 

(3)

We entered into a JV to own the real estate and develop a 110-unit ILF/ALF/MC community in Wisconsin. The commitment totals approximately $22,471.  

Shelf Registration Statement.    We have an automatic shelf registration statement on file with the SEC, and currently have the ability to file additional automatic shelf registration statements, to provide us with capacity to offer an indeterminate amount of common stock, preferred stock, warrants, debt, depositary shares, or units. We may from time to time publicly raise capital under our automatic shelf registration statement in amounts, at prices, and on terms to be announced when and if the securities are offered. The specifics of any future offerings, along with the use of proceeds of any securities offered, will be described in detail in a prospectus supplement, or other offering materials, at the time of the offering.

Distributions.    We declared and paid the following cash dividends (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

 

2018

 

2017

 

2016

 

 

 

 

Declared

 

Paid

 

Declared

 

Paid

 

Declared

 

Paid

 

 

Common Stock

 

$

90,372

(1)

$

90,372

(1)

$

90,219

(1)

$

90,219

(1)

 

84,568

(2)

 

84,568

(2)

 


(1)

Represents $0.19 per share per month for the years ended December 31, 2018, and 2017.

 

(2)

Represents $0.18 per share per month for January through September 2016 and $0.19 per share per month for October through December 2016.

 

In January 2019, we declared a monthly cash dividend of $0.19 per share on our common stock for the months of January, February and March 2019 payable on January 31,  February 28 and March 29, 2019, respectively, to stockholders of record on January 23,  February 20 and March 21, 2019, respectively.

Stock Based Compensation Plans.  During 2015, we adopted, and our stockholders approved the 2015 Equity Participation Plan (the “2015 Plan”).  Under the 2015 Plan, 1,400,000 shares of common stock have been reserved for awards, including nonqualified stock option grants and restricted stock grants to officers, employees, non-employee directors and consultants. As of December 31, 2018, we have 825,457 shares of common stock reserved for awards under the 2015 Plan. The terms of the awards granted under the 2015 Plan are set by our compensation committee at its discretion.

Restricted Stock and Performance-Based Stock Units.  Restricted stock and performance-based stock units activity for the years ended December 31, 2018, 2017 and 2016 was as follows:

 

 

 

 

 

 

 

 

 

 

 

 

    

2018

    

2017

 

2016

 

Outstanding, January 1

 

 

244,181

 

 

210,573

 

 

187,347

 

Granted

 

 

156,718

 

 

143,057

 

 

127,087

 

Vested

 

 

(75,149)

 

 

(85,343)

 

 

(103,861)

 

Cancelled

 

 

 —

 

 

(24,106)

 

 

 —

 

Outstanding, December 31

 

 

325,750

 

 

244,181

 

 

210,573

 

 

 

 

 

 

 

 

 

 

 

 

Compensation expense related to restricted stock and performance based stock units for the year

 

$

5,870,000

 

$

5,247,000

 

$

4,265,000

 

 

During 2018, 2017 and 2016, we granted 156,718,  143,057 and 127,087 shares of restricted common stock and performance-based stock units, respectively, under the 2015 plan as follows:

 

 

 

 

 

 

 

 

 

 

 

No. of 

 

Price per

 

 

 

Year

 

Shares/Units

 

Share

 

Vesting Period

 

2018

 

81,819

 

$

38.18

 

ratably over 3 years

 

 

 

66,171

 

$

38.18

 

TSR targets (1)

 

 

 

8,728

 

$

41.25

 

ratably over 1 year

 

 

 

156,718

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2017

 

74,760

 

$

45.76

 

ratably over 3 years

 

 

 

57,881

 

$

45.76

 

TSR targets (1)

 

 

 

7,416

 

$

48.55

 

ratably over 1 year

 

 

 

3,000

 

$

50.50

 

ratably over 3 years

 

 

 

143,057

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2016

 

65,300

 

$

43.24

 

ratably over 3 years

 

 

 

54,107

 

$

46.87

 

TSR targets (2)

 

 

 

7,680

 

$

46.87

 

ratably over 1 year

 

 

 

127,087

 

 

 

 

 

 


(1)

Vesting is based on achieving certain total shareholder return (“TSR”) targets in 4 years with acceleration opportunity in 3 years.

 

(2)

Vesting is based on achieving certain total TSR targets in 3.7 years with acceleration opportunity in 2.7 years.

 

Subsequent to December 31, 2018, we granted 139,112 shares of restricted common stock and performance-based stock units at $46.54 per share. Out of these shares, 78,276 vest ratably from the grant date over a three-year period and 60,836 vest based on achieving certain TSR targets in 4 years with acceleration opportunity in 3 years.

At December 31, 2018, the total number of restricted common stock and performance-based stock units that are scheduled to vest and remaining compensation expense to be recognized related to the future service period of unvested outstanding restricted common stock and performance-based stock units are as follows:

 

 

 

 

 

 

 

 

 

Number

 

Remaining 

 

 

of

 

Compensation

Vesting Date

 

Awards

    

Expense

2019

 

128,214

(1)

 

4,250,000

2020

 

104,085

(2)

 

2,210,000

2021

 

93,451

(3)

 

238,000

Total

 

325,750

 

$

6,698,000


(1)

Includes 49,728 performance-based stock units. The performance-based stock units are valued utilizing a lattice-binomial option pricing model based on Monte Carlo simulations. The company recognizes the fair value of the awards over the applicable vesting period as compensation expense.

 

(2)

Includes 53,554 performance-based stock units. See (1) above for valuation methodology.

 

(3)

Includes 66,171 performance-based stock units. See (1) above for valuation methodology.

Stock Options.    During 2018, 2017 and 2016, we did not issue any stock options. Nonqualified stock option activity for the years ended December 31, 2018, 2017 and 2016, was as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average

 

 

 

Shares

 

Price

 

 

 

2018

 

2017

 

2016

 

2018

 

 

2017

 

2016

 

Outstanding, January 1

    

25,000

 

33,334

    

40,001

    

$

32.92

 

$

30.76

    

$

29.60

 

Granted

 

 —

 

 —

 

 —

 

 

n.a

 

 

n.a

 

 

n.a

 

Exercised

 

(5,000)

 

(8,334)

 

(6,667)

 

$

24.65

 

$

24.31

 

$

23.79

 

Canceled

 

 —

 

 —

 

 —

 

 

n.a

 

 

n.a

 

 

n.a

 

Outstanding, December 31

 

20,000

 

25,000

 

33,334

 

$

34.99

 

$

32.92

 

$

30.76

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable, December 31(1)

 

20,000

 

25,000

 

28,334

 

$

34.99

 

$

32.92

 

$

45.45

 


(1)

The aggregate intrinsic value of exercisable options at December 31, 2018, based upon the closing price of our common shares at December 31, 2018, the last trading day of 2018, was approximately $134,000. Options exercisable at December 31, 2018, 2017 and 2016 have a weighted average remaining contractual life of approximately 3.3 years, 3.5 years, and 2.9 years, respectively.

 

The options exercised during 2018, 2017 and 2016 were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

Options

 

Exercise

 

Option

 

Market

 

 

 

Exercised

 

Price

 

Value

 

Value (1)

 

2018

 

5,000

 

$

24.65

 

$

123,000

 

$

205,000

 

2017

 

8,334

 

$

24.31

 

$

202,000

 

$

410,797

 

2016

 

6,667

 

$

23.79

 

$

159,000

 

$

311,000

 


(1)

As of the exercise dates.

 

We use the Black‑Scholes‑Merton formula to estimate the value of stock options granted to employees. This model requires management to make certain estimates including stock volatility, expected dividend yield and the expected term. Compensation expense related to the vesting of stock options for the years ended December 31, 2018, 2017 and 2016 was $0,  $2,000 and $15,000, respectively.